Top Markets
#1 ADO Protocol ADO Protocol +328.64%
#2 Tutorial Tutorial +69.13%
#3 GoPlus Security GoPlus Security +51.87%
#4 Nockchain Nockchain +49.89%
#5 Starpower Starpower +34.29%
#6 The Black Bull The Black Bull +30.57%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.24%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +17.46%
#10 Test Test +15.53%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Concord Drugs Limited Concord Drugs Limited

Concord Drugs Limited

CONCORD
Rank in Stocks #32979
Established on April 24, 1995, Concord Drugs Limited is a pharmaceutical firm... Established on April 24, 1995, Concord Drugs Limited is a pharmaceutical firm based in Hyderabad, India, dedicated to manufacturing and distributing a broad spectrum of medicinal formulations. Its extensive product line encompasses ready-to-fill pellets, specialized MUP's tissue bio-adhesives, injectable drugs, a variety of oral solid dosages, and liquid oral preparations.
Share Price
$0.77692576
Market Cap
$8.63M
Change (1 day)
-3.50%
Change (1 year)
30.92%
Country
IN
Trade Concord Drugs Limited (CONCORD)

Category

Healthcare
Revenue for Concord Drugs Limited (CONCORD)
Revenue in Aug 2026 TTM: 0
According to Concord Drugs Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Concord Drugs Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US